Advancing Pharmaceutical Research in Lebanon
Lebanon's first bioequivalence and biomedical research center, built to international standards and dedicated to the conduct of high-quality studies supporting the approval of safe and effective generic medications.
A New Era for Pharmaceutical Research
The Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research is a state-of-the-art facility located within the LAU Research Zone on the Byblos campus. As Lebanon's first dedicated bioequivalence research center, Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research bridges the gap between academia, industry, and regulatory bodies to position Lebanon as a regional leader in pharmaceutical research and innovation. Our mission is to provide high-quality bioequivalence studies that meet international regulatory standards, thus supporting the approval of safe, effective, and affordable generic products in the Middle East as well as other regions.
Lebanon's pharmaceutical market has faced significant challenges in recent years. With rising costs and limited access to branded medications, confidence in quality generic drugs has never been more critical. Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research exists to provide the rigorous testing that evaluates this equivalence, ensuring that when patients switch to generics, they receive the same therapeutic benefit. Research published by the U.S. FDA demonstrates that approved generic drugs differ by an average of less than 4% in bioavailability when compared to their branded counterparts.
Building Confidence in Generic Medications
Setting the Standard for Pharmaceutical Research
First in Lebanon
The country's first dedicated bioequivalence research facility, pioneering pharmaceutical research standards in the region.
International Standards
Fully compliant with ICH guidelines, with studies designed for acceptance by regulatory authorities across multiple countries.
Backed by the Lebanese American University's century-long commitment to education, research, and community impact.
Academic Excellence
Fully Digital Infrastructure
Use of Laboratory Information Management Systems (LIMS) in combination with Electronic Lab Notebook (ELN) planned as the Center’s research portfolio and study volume grow, offers experiment automation and electronic recording of procedures. A capability rare in the MENA region.
Building the Future of Pharmaceutical Research
Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research welcomes collaboration with pharmaceutical companies, research institutions, and regulatory bodies committed to advancing healthcare in Lebanon and the MENA region.